Macrotumor engineering

Patent metadata

Field	Value
Publication number	US-12006509-B2
Application number	US-202016896278-A
Country	US
Kind code	B2
Filing date	Jun 9, 2020
Priority date	Jun 19, 2019
Publication date	Jun 11, 2024
Grant date	Jun 11, 2024

Abstract

A collagen-fibronectin-based method enables the production of tumors of centimeter size with recognizable pathological traits. The method supports reproducing tumor heterogeneity with preinvasive and invasive phenotypes and stacking of tumor portions using a paper-scaffold with 80 μm-punched holes for larger nodule creation and easy separation of tumor portions for analysis. Macrotumors are convenient for testing drug delivery and therapeutic tools that necessitate a minimum tumor size relevant to in vivo.

First claim

The invention claimed is:

1. A composition comprising a multilayer stacking for culturing macrotumors, wherein the multilayer stacking comprises a plurality of cell culture-amenable substrates and a plurality of cell pellets comprising a plurality of microtumor nodules of cancer cells, wherein the cell culture-amenable substrates and the cell pellets are stacked alternatively and are embedded in one or more extracellular matrices, wherein each substrate is separable and has a plurality of micro-machined holes with a diameter of 60-100 μm, which enable the formation of macrotumors with a diameter of 0.5 cm or more, wherein the density of the micro-machined holes on each substrate is 2-8 holes/cm 2 , and wherein each substrate and cell pellet is pre-coated with one or more extracellular matrices.

2. The composition of claim 1 , wherein the multilayer stacking comprises 2-4 cell culture-amenable substrates.

3. The composition of claim 1 , wherein said cell culture-amenable substrates comprise a polymeric material.

4. The composition of claim 1 , wherein the polymeric material is selected from cellulose acetate, polystyrene, polyurethane, polytetrafluoroethylene (PTFE), polyvinylchloride, polycarbonate, SU-8, or any combination thereof.

5. The composition of claim 1 , wherein the one or more extracellular matrices of the multilayer stacking have has a stiffness of 500-8,000 Pa as measured by indentation of unconstrained samples.

6. The composition of claim 1 , wherein the one or more extracellular matrices are selected from collagen I, fibronectin, collagen III, collagen IV, laminins, hyaluronic acid, heparan sulfate proteoglycan, or a combination thereof.

7. The composition of claim 1 , wherein the extracellular matrices used to pre-coat the culture amenable substrate and the cell pellet can be the same or different.

8. The composition of claim 1 , wherein the macrotumor size is 0.5 cm to 1.5 cm.

9. A method of preparing a macrotumor, comprising:
a) providing a first cell pellet comprising a plurality of microtumor nodules of cancer cells and diameters of 50-800 μm, wherein the first pellet is pre-coated with one or more extracellular matrices;
b) providing a first cell culture-amenable substrate, wherein the first substrate has a plurality of micro-machined holes with a diameter of 60-100 μm, wherein the density of the micro-machined holes on each substrate is 2-8 holes/mm 2 , and the first substrate is pre-coated with one or more extracellular matrices, and depositing the first cell pellet comprising a plurality of microtumor nodules onto the first cell culture-amenable substrate;
c) adding one or more extracellular matrices onto the first pellet deposited on the first substrate to allow the first cell pellet to be embedded by the extracellular matrix;
d) depositing on top of the extracellular matrix of the first cell pellet a second cell culture-amenable substrate, wherein the second substrate has a plurality of micro-machined holes with a diameter of 60-100 μm, wherein the density of the micro-machined holes on each substrate is 2-8 holes/mm 2 , and the second substrate is pre-coated with one or more extracellular matrices, and placing a second cell pellet comprising a plurality of microtumor nodules onto the second cell culture-amenable substrate, wherein the second pellet is pre-coated with one or more extracellular matrices;
e) adding one or more extracellular matrices onto the second cell pellet deposited on the second substrate to allow the second cell pellet to be embedded by the extracellular matrix;
f) optionally repeating steps d)-e) to provide a total of 2-4 cell culture-amenable substrates, wherein each cell pellet comprising a plurality of microtumor nodules and each substrate are stacked alternatively; and
g) incubating the obtained multilayer stacking in a cell culture medium, wherein each cell culture-amenable substrate is separable, upon which a macrotumor with a diameter of 0.5 cm or more is formed.

10. The method of claim 9 , wherein the microtumor nodules can be the same or different to provide homogeneous or heterogeneous macrotumors.

11. The method of claim 9 , wherein the microtumor nodules are from cells representing different types of carcinomas.

12. The method of claim 9 , wherein said one or more extracellular matrices is selected from collagen I, fibronectin, collagen III, collagen IV, laminins, hyaluronic acid, heparan sulfate proteoglycan, or a combination thereof.

13. The method of claim 9 , wherein the extracellular matrices used to pre-coat the culture-amenable substrate and the cell pellet can be the same or different.

Assignees

• Purdue Research Foundation

Inventors

• Lelievre Sophie Andree
• Rahimi Rahim
• Kwok Tim

Classifications

• C12N5/0693

  Tumour cells; Cancer cells · CPC title

• C12N2533/54

  Collagen; Gelatin · CPC title

• C12N2533/52

  Fibronectin; Laminin · CPC title

• C12N2533/30

  Synthetic polymers · CPC title

• C12N2533/80

  Hyaluronan · CPC title